N-PORT filing recap · December 2023
What did Meridian Contrarian Fund buy in December 2023?
Reported stock-position changes between this filing and the previous one. These are Meridian Contrarian Fund's own holdings, not the firm's.
Stock value
$569.51M
Positions
65
Estimated turnover
28.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
CLXClorox Co /de/$9.84Mreported value+69.0K sharesVFCV. F. Corporation$6.07Mreported value+323.0K sharesMIRMirion Technologies, Inc.$3.79Mreported value+370.0K sharesATZAFAritzia Inc$3.37Mreported value+160.0K sharesCSTMConstellium SE$3.13Mreported value+156.9K sharesINBXInhibrx Biosciences, Inc.$2.89Mreported value+76.0K sharesFDMT4d Molecular Therapeutics, Inc.$2.03Mreported value+100.0K shares